Brief: Avadel Pharmaceuticals Q4 EPS USD -0.32
04/03/2024 11:30
Mar 04 (Reuters) - Avadel Pharmaceuticals Q4 basic EPS USD -0.32. * Q4 pretax profit USD -28.886 million * Q4 net income USD -28.786 million * Q4 operating income USD -24.9 million * Q4 operating expenses USD 43.66 million
Recent news on Avadel Pharmaceuticals
See all newsBrief: Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 08:10 AM
H Lundbeck steps down from takeover for Avadel, shares rise 3%
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet